{"anticipatedPostingDate":"2027-09","denomUnitsSelected":"Participants","description":"PFS is defined as the time from randomization until first documentation of progression or death from any cause, whichever occurs first, as assessed by the investigator per iwCLL guidelines with modifications for treatment-related lymphocytosis in participants with CLL and the Revised Criteria for Response for Malignant Lymphoma in participants with SLL.","reportingStatus":"NOT_POSTED","timeFrame":"Up to 5 years","title":"Cohort 1: Progression-free Survival (PFS) Between Treatment Groups Determined by Investigator Assessment (IA)","type":"SECONDARY"}